varsha chungde
☆    

India,
2018-10-08 11:34
(986 d 03:01 ago)

Posting: # 19415
Views: 2,852
 

 Enoxaparin sodium injection BA BE studies [Regulatives / Guidelines]

Hi all,

As per guideline we need not to perform any Bioequivalence studies for Injectables. But Enoxaparin sodium being a biologically derived product, is there any need of performing the BA-BE studies.

Does the guideline differs for a biologically derived product?:confused::confused:confused:
Helmut
★★★
avatar
Homepage
Vienna, Austria,
2018-10-08 11:53
(986 d 02:43 ago)

@ varsha chungde
Posting: # 19416
Views: 2,594
 

 BE of parenterals

Hi Varsha,

» As per guideline we need not to perform any Bioequivalence studies for Injectables.

It’s not that simple. See e.g., the EMA’s GL page 23.

» But Enoxaparin sodium being a biologically derived product, is there any need of performing the BA-BE studies.

That’s not the point. See the FDA’s guidance for conditions whether the in vivo PD (!) study can be waived.

» Does the guideline differs for a biologically derived product?

Differ to what? To get an idea, see the EMA’s guidelines on biosimilars.

Dif-tor heh smusma 🖖
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
nobody
nothing

2018-10-09 10:42
(985 d 03:53 ago)

@ varsha chungde
Posting: # 19418
Views: 2,479
 

 Enoxaparin sodium injection BA BE studies

» As per guideline we need not to perform any Bioequivalence studies for Injectables.

That's simply not true at all.

There is a (draft) US guidance on BE for enoxaparine. Good starting point. Have fun!

Kindest regards, nobody
varsha chungde
☆    

India,
2018-10-10 07:09
(984 d 07:27 ago)

@ nobody
Posting: # 19423
Views: 2,408
 

 Enoxaparin sodium injection BA BE studies

» There is a (draft) US guidance on BE for enoxaparine. Good starting point. Have fun!

The draft guidance says that we need to prove the sameness between API.


Edit: Full quote removed. Please delete everything from the text of the original poster which is not necessary in understanding your answer; see also this post #5[Helmut]
ElMaestro
★★★

Denmark,
2018-10-09 11:13
(985 d 03:23 ago)

@ varsha chungde
Posting: # 19419
Views: 2,485
 

 Enoxaparin sodium injection BA BE studies

Hello varsha,

» As per guideline we need not to perform any Bioequivalence studies for Injectables.

You mean solutions. :-D

Pass or fail!
ElMaestro
varsha chungde
☆    

India,
2018-10-10 07:11
(984 d 07:24 ago)

@ ElMaestro
Posting: # 19424
Views: 2,431
 

 Enoxaparin sodium injection BA BE studies

» You mean solutions. :-D

Yes i mean injectable aqueous solution. As enoxaparin injection is API in aqueous solution. But enoxaparin being a biotech product, i just needed an clarification. Do we need to prove our AP to be similar or good enough to waive the BE studies.


Edit 2018-10-10 07:14: The draft guidance also says to prove the sameness of API. [Varsha]


Edit: Full quote removed. Please delete everything from the text of the original poster which is not necessary in understanding your answer; see also this post #5! Merged with a later (deleted) post. You can edit your post within 24 hours. [Helmut]
Activity
 Admin contact
21,530 posts in 4,499 threads, 1,523 registered users;
online 10 (0 registered, 10 guests [including 6 identified bots]).
Forum time: Sunday 14:36 CEST (Europe/Vienna)

Intellect distinguishes between the possible and the impossible;
reason distinguishes between the sensible and the senseless.
Even the possible can be senseless.    Max Born

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5